文献速递瓣膜外科

人工腱索置换二尖瓣修复术后修复失败机制分析

Mechanisms of Repair Failure After Mitral Valve Repair Using Chordal Replacement.
PubMed 文献 · Ann Thorac Surg · 2024-11-26

该回顾性观察研究分析了德国慕尼黑心脏中心2003至2010年间344例因退行性二尖瓣反流接受单纯人工腱索置换联合瓣环成形术的患者,平均随访9.7年,38例(11.0%)需再次手术,失败机制为疾病进展(39.5%)、技术失败(36.8%)和心内膜炎(18.4%),再次修复占28.9%,二尖瓣置换占63.2%。

要点

  • 人工腱索置换术后再手术率11.0%,平均再手术时间6.8年。
  • 修复失败主因为疾病进展、技术失败和心内膜炎。
  • 技术失败者多可行再次修复,瓣膜硬化者多需瓣膜置换。

核心结论

  • 人工腱索置换二尖瓣修复术后再手术可行多种修复方法,包括经导管解决方案。
  • 技术失败病例更常可行再次修复,瓣膜硬化患者再手术时更常需二尖瓣置换。

研究设计与样本

  • 回顾性观察研究,纳入2003至2010年德国慕尼黑心脏中心因退行性二尖瓣反流接受单纯人工腱索置换联合瓣环成形术的344例患者。
  • 分析再手术病例的修复失败机制,平均随访9.7年(范围0-15.9年)。

主要发现

  • 38例(11.0%)需二尖瓣再手术,再手术平均时间6.8年(范围0-14.1年)。
  • 修复失败机制为疾病进展39.5%、技术失败36.8%、心内膜炎18.4%。
  • 再次修复占28.9%,采用再次瓣环成形术90.9%、人工腱索置换90.9%、切除技术27.3%、瓣叶补片重建9.1%。
  • 1例(2.6%)接受经导管缘对缘修复作为再手术。
  • 二尖瓣置换占63.2%;二尖瓣置换后24例中3例、再次修复后11例中2例需再次再手术,中位时间3.8年(范围0.01-10.04年)。

临床怎么用

  • 对人工腱索置换术后修复失败者,应评估技术失败与瓣膜硬化情况以选择再次修复或瓣膜置换。
  • 技术失败病例可优先考虑再次修复,瓣膜硬化患者再手术时需准备二尖瓣置换。
  • 再手术策略可包括再次瓣环成形、人工腱索置换、切除技术及经导管缘对缘修复。

局限性

  • 回顾性观察研究,单中心经验,样本来自特定时间段。
  • 再手术病例数较少(38例),部分亚组分析样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mechanisms of repair failure after mitral valve repair (MVr) using chordal replacement and annuloplasty for degenerative mitral regurgitation were analyzed. METHODS: All mitral valve reoperations after isolated MVr using solely chordal replacement and annuloplasty for degenerative mitral regurgitation at the German Heart Center Munich (Munich, Germany) were reviewed. This retrospective observational study aimed to analyze mechanisms of repair failure leading to reoperations. RESULTS: Between 2003 and 2010, a total of 344 patients underwent MVr with chordal replacement and annuloplasty. During a mean follow-up of 9.7 years (range, 0-15.9 years), reoperation on the mitral valve was necessary in 38 (11.0%) cases. Reoperations were performed after a mean of 6.8 years (range, 0-14.1 years). The mechanisms of MVr failure were disease progression (39.5%), technical failure (36.8%), and endocarditis (18.4%). Re-repair was performed in 28.9% and was accomplished using redo annuloplasty (90.9%), chordal replacement (90.9%), resection techniques (27.3%), and leaflet patch reconstruction (9.1%). One patient (2.6%) underwent transcatheter edge-to-edge repair for reoperation. Mitral valve replacement (MVR) was necessary in 63.2%. Redo MVr was mainly performed in cases of technical failure, and MVR was more frequently performed in patients with mitral valve sclerosis. Repeat reoperation was necessary in 3 of 24 cases of MVR and in 2 of 11 cases of redo MVr after a median of 3.8 years (range, 0.01-10.04 years). CONCLUSIONS: MVr using chordal replacement allows a variety of methods for re-repair, including transcatheter solutions. Redo MVr is more often feasible in cases of technical failure, whereas MVR for reoperation is more frequently necessary in patients with mitral valve sclerosis.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lang M, Feirer N, Voss B, et al. Mechanisms of Repair Failure After Mitral Valve Repair Using Chordal Replacement. Ann Thorac Surg. 2024. PMID: 39603581. doi:10.1016/j.athoracsur.2024.10.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。